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ABSTRACT
In mammals, microRNAs (miRNAs) can play diverse roles in viral infection through their capacity to regulate both host and viral
genes. Recent reports have demonstrated that specific miRNAs change in expression level upon infection and can impact viral
production and infectivity. It is clear that miRNAs are an integral component of viral–host interactions, and it is likely that both
host and virus contain mechanisms to regulate miRNA expression and/or activity. To date, little is known about the mechanisms
by which miRNAs are regulated in viral infection. Here we report the rapid down-regulation of miR-27a in multiple mouse cell
lines as well as primary macrophages upon infection with the murine cytomegalovirus. Down-regulation of miR-27a occurs
independently from two other miRNAs, miR-23a and miR-24, located within the same genomic cluster, and analysis of pri-
miRNA levels suggest that regulation occurs post-transcriptionally. miR-27b, a close homolog of miR-27a (20/21 nucleotide
identity), also decreases upon infection, and we demonstrate that both miR-27a and miR-27b exert an antiviral function upon
over-expression. Drug sensitivity experiments suggest that virus entry is not sufficient to induce the down-regulation of miR-27
and that the mechanism requires synthesis of RNA. Altogether, our findings indicate that miR-27a and miR-27b have antiviral
activity against MCMV, and that either the virus or the host encodes molecule(s) for regulating miR-27 accumulation, most
likely by inducing the rapid decay of the mature species.
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INTRODUCTION
RNA silencing is a widespread phenomenon conserved in all
eukaryotes from the unicellular fungi to human. Small non-
coding RNAs, 19–30 nucleotides (nt) in size, are invariably
found at the core of all RNA silencing pathways (Farazi et al.
2008). They exert their activity by directing protein com-
plexes to the nucleic acid targets, enabling various modes of
regulation. In mammals, miRNAs constitute an important
and diverse class of noncoding RNA (Ambros 2004; Bartel
2004) with more than 700 and 540 miRNA genes identified
in human and mouse, respectively (Griffiths-Jones et al.
2008). Their biogenesis involves several processing steps,
starting with a large primary transcript and ending with
a z22-nt double-stranded RNA; the functional strand from
this duplex is then incorporated into an RNA-induced
silencing complex (RISC) that invariably contains a member
of the Argonaute protein family (for review, see Bartel 2004;
Meister and Tuschl 2004; Du and Zamore 2005; Kim 2005;
Okamura et al. 2008). Once loaded, the mature miRNA
remains remarkably stable with a miRNA half-life in the
range of days (Gatfield et al. 2009). The other strand, also
known as the star sequence, or ‘‘miRNA*,’’ is usually
degraded. The active RISC is directed toward its messenger
RNA target to regulate, predominantly negatively, translation
of the message (for review, see Pillai et al. 2007; Eulalio et al.
2008).
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In addition to their regulatory roles in diverse biological
pathways, miRNAs have also been associated with viral in-
fections. The most striking association between viruses and
miRNAs is the usurpation of miRNAs themselves by some
mammalian viruses, such as herpesviruses or polyomaviruses
(Cullen 2006; Pfeffer 2008). In this case, miRNAs of viral
origin are beneficial for the viruses and contribute, in a
nonimmunogenic manner, to the establishment of ideal con-
ditions for the infection to occur. At the other range of the
spectrum, unbeneficial interactions between cellular miRNAs
and viruses have also been reported. Here, miRNAs of
cellular origin can negatively impact viral infection either
by targeting the viral genome itself, or by regulating cellular
genes essential for the replication cycle. Thus, the primate
foamy retrovirus is negatively regulated by miR-32 (Lecellier
et al. 2005), vesicular stomatitis virus (VSV) is targeted by
miR-24 and miR-93 (Otsuka et al. 2007), and HIV is targeted
by miR-29 (Ahluwalia et al. 2008; Nathans et al. 2009). This
antiviral activity of miRNAs can be perhaps paralleled to the
more general antiviral role of RNA silencing in other phyla
such as plant and insect organisms (Ding and Voinnet 2007).
On the other hand, the down-regulation of viral genes by
host miRNAs may in fact be a strategy employed by viruses
in order to evade detection by the host and establish
persistence (Pedersen et al. 2007; Mahajan et al. 2009).
Although extensive focus has been placed on uncovering
the mechanisms by which miRNAs regulate their mRNA
targets, there is a contrasting lack of information on mech-
anisms by which miRNAs themselves are regulated. This
regulation can take place at several different steps (for review,
see Winter et al. 2009): transcription of the primary tran-
script, processing of the pri- and pre-miRNAs, or stability of
the miRNA. Hence, some miRNA primary transcripts are
known to be under the control of classic transcription factors
such as E2F1 (Woods et al. 2007) or p53 (He et al. 2007).
Other miRNAs require auxiliary factors for their biogenesis,
and many miRNAs have evolutionary conserved loops that
might dictate their regulation (Michlewski et al. 2008). In line
with this, the precursor of Let-7 has been shown to recruit
the Lin-28 protein through interactions with the Let-7 loop,
leading to the pre-miRNA polyuridylation, which in turn
prevents its efficient processing (Heo et al. 2008; Rybak et al.
2008). Additionally, differential tissue-specific accumulation
of pre- and mature miR-138, a brain-specific miRNA, sug-
gests that processing of this miRNA may be inhibited under
certain conditions (Obernosterer et al. 2006). It is likely that
many more regulatory mechanisms will emerge. For example,
recent reports suggest that exoribonucleases modulate
miRNA turnover in Arabidopsis (Ramachandran and Chen
2008) and in C. elegans (Chatterjee and Grosshans 2009).
To our knowledge there are no reports so far demonstrat-
ing regulation at the level of mature miRNA stability in
mammalian systems.
We previously showed that mouse cytomegalovirus
(MCMV) encodes a total of 18 pre-miRNAs that are
abundantly expressed during lytic infection (Buck et al.
2007; Do¨lken et al. 2007). Here, we report on the mod-
ulation of cellular miRNA profiles by lytic MCMV infec-
tion. Despite the high level of expression of viral miRNAs
during lytic infection, the levels of most cellular miRNAs
are only modestly altered. In contrast, we identified one
miRNA, miR-27a, which is rapidly down-regulated. MiR-23a
and miR-24, two miRNAs clustered within 400 bp of miR-
27a, are not affected by MCMV infection, and analysis of
the pri-miRNA(s) suggests that regulation of mir-27a occurs
post-transcriptionally. miR-27b, which differs from miR-27a
by only one nucleotide, is similarly down-regulated and
overexpression of either miR-27a or miR-27b results in
a log-fold defect in viral replication, suggesting an antiviral
function of these miRNAs. Drug sensitivity experiments
further show a dependency on RNA synthesis for miR-27
down-regulation. The results presented here suggest that
either the virus or the host encodes molecule(s) for regulating
miR-27 accumulation, most likely at the level of mature
miRNA stability.
RESULTS AND DISCUSSION
Down-regulation of miR-27a in murine
cytomegalovirus infection
Many studies have demonstrated changes in host miRNA
expression levels in response to viral infection (for review,
see Gottwein and Cullen 2008; Ghosh et al. 2009). Depend-
ing on the kinetics of viral replication, the miRNA com-
position of infected cells could influence the ability of a
virus to replicate or spread, since many pathways (cell cycle,
apoptosis, immune response) are modulated by miRNAs.
Manipulation of the host miRNome could therefore be used
by either virus or host as part of their evolutionary strategies
for survival (Obbard et al. 2009). In the lytic stage of
MCMV infection, abundant viral-encoded miRNAs are ex-
pressed that could theoretically alter, or saturate, the host
miRNA composition. We previously reported that virus-
encoded miRNAs dominate the small RNA content of NIH-
3T3 fibroblasts infected with murine cytomegalovirus (35%
of clones at 24 hours post-infection [hpi] and 60% of
clones at 72 hpi) (Do¨lken et al. 2007). If viral-encoded
miRNAs were to saturate components of the miRNA ma-
chinery, this could lead to a global impact on host miRNA
content. Supplemental Table 1 is provided, which details all
changes in host miRNAs upon MCMV infection of NIH-
3T3 cells. Analysis of the top 25 most abundant mouse
miRNAs in these cells (which altogether represent 80% of
cloned miRNAs) indicates that the global profile of cellular
miRNAs is not dramatically altered upon MCMV infection
(Fig. 1A, top panel). Quantitative real-time PCR (qRT-
PCR) analysis confirms that some of the miRNAs display
subtle changes and fluctuations over the time course of the
infection (Fig. 1B). Qualitatively, the results obtained from
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cloning versus qRT-PCR display the same trends (given the
technical aspects of both approaches and the low number
of clones analyzed, we would expect a certain level of
variability). In addition to the observed fluctuations, one
glaring observation is the down-regulation of miR-27a,
which represents 6% of all cloned miRNAs in mock-
infected cells, but only 0.1% after 24 h of infection (Fig.
1A, arrow). MiR-27a is located on chro-
mosome 8 and is proximal to two other
miRNAs, miR-23a and miR-24-2. Nei-
ther miR-24 nor miR-23a clone numbers
display such a substantial drop-off upon
infection (Fig. 1A, arrowheads; Supple-
mental Table 1). To confirm the specific
down-regulation of miR-27a, we ana-
lyzed the expression levels of miR-23a,
miR-27a, and miR-24 at various times
after infection using Northern blot.
MiR-27a expression levels drop rapidly
by 4 h and 8 h post-infection (hpi) to
become barely detectable after 24 hpi,
while the levels of miR-24 and miR-23a
do not significantly change (Fig. 1C).
Another locus on chromosome 13 en-
codes homologs of the three miRNAs:
miR-23b, miR-27b, and miR-24-1 (Fig.
1D). There is a 1-nt difference in the 39
end of the mature ‘‘a’’ and ‘‘b’’ forms of
miR-27 and miR-23 that allows them to
be distinguishable by cloning (the ma-
ture miR-24 sequence is identical in both
clusters). As shown in the bottom panel
of Figure 1A and in Supplemental Table
1, miR-27b and miR-23b were cloned in
fewer numbers than the miR-27a and
miR-23a counterparts in these cells, yet
the pattern of down-regulation of the
miR-27 species is preserved. Since the
cloning numbers in this study are not
sufficient to enable statistical conclu-
sions, we validated this observation with
qRT-PCR. Using synthetic oligonucleo-
tides, qRT-PCR conditions were opti-
mized to distinguish the ‘‘a’’ and ‘‘b’’
forms of miR-27 and miR-23 (Materials
and Methods). Figure 1E demonstrates
the down-regulation of both miR-27
species upon infection, while both
miR-23 species are unaltered. Based on
the above results, we would postulate
that down-regulation of miR-27 occurs
after the production of the primary
transcript. However, we cannot rule out
the possibility that miR-27 derives from
a pri-miRNA that is regulated indepen-
dently of miR-23 and miR-24. Indeed, Sun et al. (2009) have
characterized the primary transcript for miR-23b, miR-27b,
and miR-24-1 and reported that three different pri-miRNAs
could co-exist: one containing all three miRNAs, one
containing only miR-27b, and one with only miR-24-1.
However, there is no evidence for independent pri-miRNAs
in the miR-23a–27a–24-2 cluster, and the miRNAs are
FIGURE 1. miR-27a and miR-27b are strongly down-regulated upon MCMV infection in
NIH-3T3 cells. (A) (Top) Top 25 host miRNAs cloned in mock and infected NIH-3T3 cells,
(bottom) miR-23 and miR-27 isoforms. For each miRNA, the percentage from total cellular
miRNAs is displayed as a heat-map, miR-27a is indicated by an arrow, and miR-24 and miR-23b
are indicated by an arrowhead. (B) Real-time PCR quantification of three miRNAs whose
expression levels are modestly impacted by MCMV infection. The fold changes relative to mock-
infected cells are displayed. (C) Northern blot analysis of miR-23a, miR-27a, and miR-24
accumulation during MCMV infection (MOI = 1 with centrifugal enhancement), (M) mock
infected, (hpi) hours post-infection. (D) Schematic representation of miR-23a/27a/24-2 and
miR-23b/27b/24-1 clusters on chromosomes 8 and 13; the position of the predicted pre-miRNAs
are indicated by white rectangles. (E) Quantitative real-time PCR analysis of miR-27a and
miR-27b and miR-23a and miR-23b in mock and infected NIH-3T3 fibroblast cells (n = 3).
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arranged in closer proximity to one another compared with
the miR-23b–27b–24-1 cluster (Fig. 1D). It seems unlikely
that miR-27a is expressed from its own primary transcript,
since no potential poly(A) binding site could be identified
inbetween miR-27a and miR-24-2, while one was found
roughly 700-nt downstream from miR-24-2 (data not
shown). It also seems probable that regulation occurs at
the level of the mature miRNA species, since both miR-27a
and miR-27b are impacted (explored further below). In the
remainder of this work we will use miR-27 to refer to both
miR-27a and miR-27b.
Functional implications of miR-27 down-regulation
In the context of viral infection, host cells can make use of
miRNAs as another arm of the innate immune response.
For example, miR-155 is up-regulated within 2 h after
treatment with poly (I:C) (O’Connell et al. 2007) or upon
infection with Epstein-Barr virus (Cameron et al. 2008;
Gatto et al. 2008). Both miR-155 and miR-146 contain NF-
kB binding sites in their promoter regions, and their
regulation is therefore tied to larger transcriptional net-
works and a coordinated host response. However, there is
limited information on the elements involved in post-
transcriptional regulation of miRNAs. It is therefore un-
clear if down-regulation of miR-27 is part of a host re-
sponse or is a viral strategy that might involve viral factors.
To date, down-regulation of miR-27 during viral infection
has not been reported. Depending on the mechanism of
miR-27 down-regulation, our observations could be spe-
cific to MCMV infection and could also be exclusive to
particular cell types. MCMV has a wide cell tropism in vivo,
infecting many cell types such as fibroblast, epithelial,
endothelial, smooth muscle, neuronal and macrophage
cells. Therefore, we analyzed miR-27a levels in a range of
cell types upon MCMV infection. In addition to the results
shown for NIH-3T3 cells (Fig. 1), miR-27a was specifically
down-regulated in the endothelial cell line SVEC4-10,
epithelial cell lines TCMK-1 and C127, as well as in primary
bone marrow-derived macrophages (all of the cells exam-
ined) (Fig. 2A,B). Down-regulation of miR-27a in fibro-
blasts displays a clear dependence on the multiplicity of
infection (MOI), with an inverse relationship between
mature miR-27a levels and the applied MOI (Fig. 2C).
The effect is qualitatively different in some cell types and is
partly attributable to MOIs used in experiments (as indi-
cated in the figure legends), which were conducted inde-
pendently in separate laboratories. These observations in-
dicate that miR-27a regulation is not cell-type-specific and
is either mediated by a factor of viral origin or by a ubiq-
uitously expressed cellular factor whose activity is altered
upon MCMV infection. Further work is required to estab-
lish the generality of our observations. Preliminary data
suggest that miR-27a is not altered upon infection with
human cytomegalovirus or mouse gammaherpesvirus 68
(data not shown). However, this is not necessarily surpris-
ing, as the evolutionary distance between MCMV and
HCMV is estimated at z80 million years (McGeoch et al.
1995), and there are a number of viral mechanisms for
modifying host cells that are not conserved between the two
viruses. Related to this, a previous study reported down-
regulation of miR-100 and miR-101 upon infection of fi-
broblasts with human cytomegalovirus (Wang et al. 2008);
we do not observe the same down-regulation upon MCMV
infection of murine fibroblast cell lines (AH Buck, unpubl.).
If modulation of miRNAs is indeed a viral strategy (rather
FIGURE 2. Down-regulation of miR-27a occurs in multiple cell types
and displays a clear dependence on the multiplicity of infection. (A)
Northern blot analysis of total RNA isolated from endothelial SVEC
cells and epithelial TMCK cells infected with MCMV at MOI = 1 with
centrifugal enhancement. (B) Northern blot analysis of total RNA
isolated from primary bone marrow macrophages and epithelial C127
cells infected with MCMV at MOI = 3 with centrifugal enhancement.
(C) qRT-PCR analysis of total RNA isolated from NIH-3T3 cells
infected with an increasing number of infectious particles (MOI of
0.1–10.0), 24 hpi.
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than a host response), it will be interesting to further
explore this parameter in the context of viral evolution.
Antiviral effects of miR-27
Based on the dramatic and rapid alteration in miR-27 levels
upon infection, we might postulate that this miRNA plays
some role in MCMV infection. Indeed, HCMV infection
alters the expression of miR-100 and miR-101, and these
miRNAs were shown to influence viral replication (Wang
et al. 2008). To examine this hypothesis, we measured viral
growth upon inhibition or overexpression of either miR-27a
or miR-27b. These experiments were carried out by trans-
fecting cells with synthetic miRNA inhibitors or mimics.
Since transfection of small RNAs has been shown to induce
immune activation in various cell types (Kariko et al. 2004;
Reynolds et al. 2006), we first examined the effect of trans-
fection on viral replication. Transfection of C. elegans miR-
67, which is not encoded in mouse cells, and RISC-free
siRNA, which is chemically modified to prevent incorpora-
tion into RISC, had no effect on the viral growth rate of
MCMV at either low or high multiplicities of infection (Fig.
3A). In contrast, transfection with miR-27a or miR-27b
mimics results in greater than a log-fold decrease in viral
titer under conditions of low MOI, and an approximately
fivefold decrease in viral titer at 2 days post-infection (dpi)
at high MOI, consistent with an antiviral function (Fig. 3B).
Under these transfection conditions, we confirmed that
miR-27a levels increased by z50- to 100-fold based on
qRT-PCR, and that these conditions did not alter cell
viability (data not shown). Theoretically, transfection of
the miR-27 inhibitors should show the opposite effect
compared with the miR-27 mimics, resulting in an increase
in viral growth rate. However, interpretation of results with
inhibitors should take into account that miR-27 is naturally
inhibited in the infected cells (Figs. 1, 2). Indeed, we
observed little effect of inhibitors on viral growth: the
miR-27b inhibitor results in an approximately twofold in-
crease in virus titer by day 4 at low MOI (P < 0.0005), but
this is not observed with the miR-27a inhibitor.
Further analysis of miR-27 targets will shed light on the
mechanism underlying the antiviral activity; this could be
based on direct targeting of viral genes or based on
targeting cellular factors essential for MCMV replication.
For example, the antiviral effect of miR-100 and miR-101
during HCMV infection could be partly explained by their
targeting of the mTOR pathway (Wang et al. 2008).
Similarly, the miRNA cluster miR-17–92 has an inhibitory
FIGURE 3. miR-27 has antiviral properties. MCMV growth curve in NIH-3T3 cells transfected with 25 nmolar C. elegans miR-67 mimic or
inhibitor and RISC-free (nontargeting) siRNA (A), or 25 nmolar miR-27a or miR-27b mimic and 50 nmolar inhibitors (B). Cells were infected at
MOI of 0.01 and 3.0. (PFU) Plaque forming units; (dpi) days post-infection.
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effect on HIV that is linked to the
targeting of the histone acetylase PCAF
by miR-17 and miR-20 (Triboulet et al.
2007). A few cellular targets for miR-27a
or miR-27b have been published; in
particular, miR-27a has been identified
as an oncogene that can impact cell
cycle regulation, proliferation, apopto-
sis, megakaryopoiesis, and lipid metab-
olism (Mertens-Talcott et al. 2007;
Guttilla and White 2009; Ji et al. 2009;
Liu et al. 2009). As discussed above,
miRNAs have also been shown to di-
rectly target viral genes. Several putative
binding sites for miR-27 can be found in
the MCMV genome (data not shown),
but based on the high probability of
finding complementarities in such a
large (z230 kb) viral genome, this re-
quires extensive validation and analysis
before drawing further conclusions.
Mechanism for miR-27 regulation
It seems likely that the regulation of
miR-27 involves post-transcriptional
mechanisms, based on the lack of change
in miR-24 and miR-23a expression levels
upon infection (Figs. 1, 2). However, it is
necessary to consider the possibility that
miR-27a derives from a pri-miRNA that
is regulated independently of miR-23a
and miR-24-2. In order to examine
whether regulation might occur at the
level of transcription (and/or at the
Drosha processing step), we used qRT-
PCR to examine changes in pri-miR-
27a and pri-miR-23a levels upon in-
fection. Primers were designed within
the loop and just 59 to the respective
hairpins. The location of these primers
should ensure that pri-miR-27a is
detected, regardless of whether it is
within a larger pri-miRNA containing
miR-23a and miR-24-2. As shown in
Figure 4A, the levels of pri-miR-27a and
pri-miR-23a are only moderately altered (less than approx-
imately twofold) upon infection. Given the similarity in
modest changes between pri-miR-27a and pri-miR-23a
upon infection (slightly down in fibroblasts and slightly
up in macrophages), it is unlikely that the rapid down-
regulation of mature miR-27a in multiple cell types is due
to specific regulation of the primary transcript. These data
are consistent with regulation of miR-27a occurring after
the production of the primary transcript.
Regulation of miR-27a could occur at several steps in the
processing pathway: pri-miRNA processing by Drosha,
export of pre-miRNA, precursor processing by Dicer, or
degradation/turnover of the mature miRNA. Different ap-
proaches can be used to tease apart regulation at each step.
For example, quantification of the pre-miRNA and/or the
miRNA* sequence would shed light on whether regulation
occurs during processing of the pre-miRNA. If the pre-
miRNA accumulates, but the mature miRNA is not detected,
FIGURE 4. miR-27a regulation occurs post-transcriptionally and requires RNA synthesis. (A)
Relative pri-miRNA and mature miRNA levels in uninfected versus infected cells, quantified
using qRT-PCR (n = 3) normalized to GAPDH or U6 RNA (respectively). Total RNA was
isolated from NIH-3T3 cells or bone marrow-derived macrophages 24 hpi with MCMV (MOI =
10 for NIH-3T3 cells and MOI = 5 with centrifugal enhancement for bone-marrow-derived
macrophage cells). (B) Large-scale Solexa sequencing of MCMV-infected NIH-3T3 cells reveals
that the ratio of miR-27a*/miR-27a is significantly higher than expected from previous
analyses in uninfected cells (Landgraf et al. 2007), whereas most of the other miR*/miR ratios
stay below 0.15. (C) Northern blot analysis of total RNA isolated from NIH-3T3 cells treated
with actinomycin D or cycloheximide (as indicated) in the absence or presence of MCMV
(MOI = 10). Though the juxtaposed lanes are not contiguous, all of them are from a single gel
(indicated by the dotted line).
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then regulation is likely occurring at processing of pre-
miRNA (and the miRNA* levels should also decrease). We
were not able to detect pre-miR-27a by Northern blot with
a number of probe designs (data not shown), most likely
because it is processed very efficiently. The passenger strand,
miR-27a*, could be detected using qRT-PCR and does not
significantly change in expression level upon infection (Fig.
4A). These data suggest a stark difference in the effect of
MCMV infection on mature miR-27a compared with the
passenger strand, miR-27a*. To further confirm the differ-
ence observed for miR-27a and miR-27a*, we made use of
Solexa sequencing data of small RNAs isolated from
MCMV-infected (48 hpi) NIH-3T3 cells. In this data set,
a total of 7,840,619 small RNAs were sequenced, of which
5,374,302 are annotated as miRNAs (the detailed analysis
will be published elsewhere). The balance between a miRNA
and its star sequence, as per definition, is lower than a ratio
of 0.15 to 1 of star vs. mature miRNA (Landgraf et al. 2007).
When the ratio is higher, both strands of the miRNA are
defined as functional and the 5p/3p nomenclature is used.
Reported ratios for miR-27a*/miR-27a are far below 0.15,
and these miRNAs have been cloned in numerous cell lines
and tissues (Landgraf et al. 2007). However, in our large-
scale sequencing data set of MCMV-infected cells, we
sequenced more clones of miR-27a* than miR-27a (for
a ratio of 35.5 miR-27a*/miR-27a, compared with 0.0014 in
the Landgraf et al. data set) (Fig. 4B). Similarly, the ratio of
miR-27b*/miR-27b was inverted in MCMV-infected 3T3
compared with the normal situation, although not as
strongly as for miR-27a. Beside miR-27a and miR-27b, only
two other miRNAs, miR-106b and miR-18a, showed a sim-
ilar trend, and all of the other miRNA*/miRNA pairs that we
cloned (including miR-24) were below the ratio of 0.15 to 1.
The qRT-PCR and cloning results suggest that miR-27a* is
not down-regulated upon MCMV infection and, thus,
processing of pre-miR-27a occurs normally. Hence, we
hypothesize that the regulation of miR-27 occurs at the
level of the stability of the mature miRNA. This suggests that
the recognition element for down-regulation of miR-27 is
contained within the mature 21-nt sequence, consistent with
the down-regulation of both miR-27a and miR-27b (Fig. 1E;
Supplemental Table 1), which differ from one another by
only 1 nt at the 39end. Regulation at the level of the mature
miRNA would involve mechanisms that are distinct from
other reported post-transcriptional mechanisms, where ele-
ments in the miRNA loop are central to recognition
(discussed above). In line with this, the loop of miR-27
does not display obvious conservation and is highly variable
between miR-27a and miR-27b (data not shown). Drug-
sensitivity experiments demonstrate that virus entry is not
sufficient to induce down-regulation of miR-27a, as it can be
blocked by actinomycin D treatment (Fig. 4C). Treatment
with cycloheximide, which blocks protein synthesis, is not as
effective at blocking down-regulation (Fig. 4C). The most
consistent model to describe all of the data presented here is
that an RNA molecule, which is synthesized upon infection,
is involved in inducing the decay or inhibition of mature
miR-27. Given that the recognition element for this mecha-
nism appears to be contained within the 21-ntmaturemiR-27
sequence, it is probable that another RNA molecule,
potentially a viral transcript, is involved in the regulatory
mechanism, enabling specificity through base pairing.
Further work is required to pin down this mechanism
and the breadth of miR-27 regulation in other viral
infections. Given the ubiquity of miRNAs in signaling
and immune responses, it is anticipated that miRNA
expression would be controlled at multiple levels and with
varying kinetic parameters. Depending on the mechanism,
regulation of mature miRNA stability might enable a rapid
host response, or provide a rapid means by which patho-
gens could inhibit miRNA function.
MATERIALS AND METHODS
Cell lines and viruses
NIH-3T3, SVEC4-10, C127, and TCMK-1 cells were grown in
DMEM supplemented with 10% FBS and penicillin/streptomycin.
Bone marrow-derived macrophages were prepared as described in
Buck et al. (2007). Wild-type virus (Smith strain) was generated
from bacterial artificial chromosome clone pSM3fr described in
Wagner et al. (1999). For experiments in NIH-3T3, SVEC4-10, and
TCMK-1 (Figs. 1, 2), virus stocks were prepared on M2-10B4 cells
and titers determined as described in Do¨lken et al. (2007). For ex-
periments in NIH-3T3 (Figs. 3, 4), C127 and bone marrow-derived
macrophages (Figs. 2, 4), virus stocks were prepared on NIH-3T3
cells as described by Buck et al. (2007). The MOI for each ex-
periment is indicated in the figure legends. To obtain a high level of
infection, centrifugal enhancement was employed during the incu-
bation with virus where indicated, as described by Do¨lken et al.
(2007). This results in an up to 10-fold higher viral load compared
with incubations without enhancement (data not shown).
RNA preparation and Northern blotting
RNA was extracted using Trizol reagent (Invitrogen) and Northern
blotting was performed on 5–10 mg of total RNA as described
before (Pfeffer et al. 2005; Do¨lken et al. 2007), except that we used
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)-mediated,
chemical cross-linking (Pall and Hamilton 2008) instead of UV
cross-linking. Probes were 59 32P-radiolabeled oligodeoxynucleo-
tides perfectly complementary to the miRNA sequence or to part of
the U6 snRNA sequence. Blots were analyzed and quantified by
phosphorimaging using an FLA5100 scanner from Fuji.
miRNA and pri-miRNA quantification
by quantitative real-time PCR
For experiments with NIH-3T3 cells in Figure 1, quantitative real-
time PCRs were established using a Roche LightCycler 480 Real-
Time PCR System. For mature miRNAs, total RNA was poly-
adenylated and reverse transcribed using the miScript Reverse
Transcription kit (QIAGEN) as per the manufacturer’s instructions
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with 1 mg of total RNA per reaction. The obtained cDNA (1 mL of
a 1/5 dilution) was then PCR-amplified using the miScript SYBR
Green PCR kit (QIAGEN) in 10 mL reaction mixtures consisting of
Quantitect SYBR Green PCR master mix and 0.625 mM of the
miRNA-specific primer and the miScript universal primer. PCRs
were subjected to 15 min of 95°C hot-start enzyme activation, and
40 cycles of 95°C denaturation for 15 sec, 55°C annealing for 30 sec,
and 72°C elongation for 30 sec, including subsequent melting curve
analysis. The data was analyzed using the DDCt method (Bookout
et al. 2006) using U6 snRNA as an endogenous reference, and the
mock-infected sample as a calibrator. The amplification efficiency
as determined with the LinReg software (Ramakers et al. 2003) was
used to calculate fold changes relative to mock. Primers were the
mature miRNA sequences for the forward primers, and the
universal miScript primer provided by QIAGEN for the reverse
primer. The primer specific for miR-27b could discriminate miR-
27b from miR-27a with a cycle difference of 7.3 (i.e., a 168.9-fold
difference), and the primer for miR-23a could discriminate miR-
23a from miR-23b with a cycle difference of 6.5 (a 90.5-fold
difference). Similar results were obtained with primers specific for
miR-27a and miR-23b, and the use of synthetic standards also
allowed us to calculate that there is sixfold more miR-27a than
miR-27b in NIH-3T3 fibroblasts. For detection of pri-miRNAs,
cDNA was prepared using ThermoScript reverse transcriptase
(Invitrogen) according to the manufacturer’s protocol (at a tem-
perature of 55°C) with gene-specific primers for pri-miR-23a and
pri-miR-27a and the oligo dT primer for GAPDH (similar results
were obtained when comparing pri-miR-23a and pri-miR-27a in
uninfected and infected cells using cDNA prepared with either the
gene-specific primers or the oligo dT primer). cDNAs were am-
plified using SYBR green SuperMix (Invitrogen) with the following
primers:
pri-miR-27a forward, 59-CTATCATGACAACTGGCCTGAG-39;
pri-miR-27a reverse, 59-GACTTTGCTGTGGACCTTGC-39;
pri-miR-23a forward, 59-CTACACTCCGCTCCCACC-39;
pri-miR-23a reverse, 59-TTGTGACTGGCATCAAATCC-39;
GAPDH forward, 59-AATGTGTCCGTCGTGGATCT-39; and
GAPDH reverse, 59-CCTGCTTCACCACCTTCTTG-39.
Detection of miR-27a and miR-27a* in Figure 4A was performed
using miRCURY LNA qRT-PCR probes (Exiqon) according to the
manufacturer’s protocols (using 100 ng input RNA); standard
curves were performed with synthetic RNAs (Eurogentec).
Small RNA cloning and analysis
The generation of small RNA libraries used in the initial analysis
has been described before (Do¨lken et al. 2007). For the generation
of Solexa-compatible libraries, the protocol was modified accord-
ing to Hafner et al. (2008), and 3 pmol of the final PCR product
were used for sequencing on one lane of an Illumina flow cell
using the DGE-Small RNA Cluster Generation Kit—GA II and
the 36-cycle sequencing kit V. Adaptor sequences were removed
and sequences annotated as described before (Do¨lken et al.
2007), except that the databases used were miRbase release 13.0,
GenBank release 169, and the mm9 version of the mouse genome,
with the Illumina pipeline scripts v.1.3.2. The hierarchical clus-
tering analysis described in Figure 1A was done using the Multi-
Experiment Viewer version 4.4 from the TM4 software suite
(Saeed et al. 2003).
Viral growth assays and microRNA transfections
NIH-3T3 cells were reverse transfected with miRNA mimics
(25 nM) or inhibitors (50 nM) (Dharmacon) using 0.4%
Dharmafect 1 in a 96-well plate format. Cells were seeded at
1.5 3 104 cells/well in antibiotic-free media and were incubated
48 h at 37° C and 5% CO2 prior to infection with MCMV. Super-
natant from the infected cells was collected over a period of 6 dpi,
and the viral titer measured by standard plaque assay on mouse
embryonic fibroblast p53 cell line.
SUPPLEMENTAL MATERIAL
Supplemental material can be found at http://www.rnajournal.org.
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